Publications of Research Area A7
Mechanisms and implications of NKG2D ligand shedding
Teilprojektleiter: Dieter Kabelitz
- [Toll-like receptors: recognition receptors of the innate immune system and target structures for therapeutical intervention].Kabelitz D. Med Monatsschr Pharm. 2012 Jul;35(7):238-44.
- poly(I:C) costimulation induces a stronger antiviral chemokine and granzyme B release in human CD4 T cells than CD28 costimulation.Meyer T, Oberg HH, Peters C, Martens I, Adam-Klages S, Kabelitz D, Wesch D.J Leukoc Biol. 2012 Oct;92(4):765-74.
- The Multifunctionality of Human Vγ9Vδ2 γδ T Cells: Clonal Plasticity or Distinct Subsets?Kabelitz D, He W. Scand J Immunol. 2012 Sep;76(3):213-22.
- Aminobisphosphonates and Toll-like receptor ligands: recruiting Vγ9Vδ2 T cells for the treatment of hematologic malignancy.Kalyan S, Wesch D, Kabelitz D. Curr Med Chem. 2011;18(34):5206-16.
- [T-cells in ANCA-associated vasculitis]. Lamprecht P, Kabelitz D. Z Rheumatol. 2011 Oct;70(8):698-700.
- Cutting Edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients. Hutchinson JA, Riquelme P, Sawitzki B, Tomiuk S, Miqueu P, Zuhayra M, Oberg HH, Pascher A, Lützen U, Janssen U, Broichhausen C, Renders L, Thaiss F, Scheuermann E, Henze E, Volk HD, Chatenoud L, Lechler RI, Wood KJ, Kabelitz D, Schlitt HJ, Geissler EK, Fändrich F. J Immunol. 2011 Sep 1;187(5):2072-8.
- Modulation of γδ T cell responses by TLR ligands. Wesch D, Peters C, Oberg HH, Pietschmann K, Kabelitz D. Cell Mol Life Sci. 2011 Jul;68(14):2357-70.
- γδ T-cells: cross-talk between innate and adaptive immunity. Kabelitz D. Cell Mol Life Sci. 2011 Jul;68(14):2331-3.
- Functional expression of NOD2 in freshly isolated human peripheral blood γδ T cells.Marischen L, Wesch D, Oberg HH, Rosenstiel P, Trad A, Shomali M, Grötzinger J, Janssen O, Tchikov V, Schütze S, Kabelitz D. Scand J Immunol. 2011 Aug;74(2):126-34
- Regulation of T cell activation by TLR ligands. Oberg HH, Juricke M, Kabelitz D, Wesch D. Eur J Cell Biol. 2011 Jun-Jul;90(6-7):582-92.
- Effector granules in human T lymphocytes: the luminal proteome of secretory lysosomes from human T cells.Schmidt H, Gelhaus C, Nebendahl M, Lettau M, Lucius R, Leippe M, Kabelitz D, Janssen O. Cell Commun Signal. 2011 Jan 21;9(1):4
- Effector granules in human T lymphocytes: proteomic evidence for two distinct species of cytotoxic effector vesicles.Schmidt H, Gelhaus C, Nebendahl M, Lettau M, Lucius R, Leippe M, Kabelitz D, Janssen O. J Proteome Res. 2011 Apr 1;10(4):1603-20
- Novel splice variants of human IKKε negatively regulate IKKε-induced IRF3 and NF-kB activation. Koop A, Lepenies I, Braum O, Davarnia P, Scherer G, Fickenscher H, Kabelitz D, Adam-Klages S. Eur J Immunol. 2011 Jan;41(1):224-34.
- Caspase-8 and caspase-7 sequentially mediate proteolytic activation of acid sphingomyelinase in TNF-R1 receptosomes.Edelmann B, Bertsch U, Tchikov V, Winoto-Morbach S, Perrotta C, Jakob M, Adam-Klages S, Kabelitz D, Schütze S. EMBO J. 2011 Jan 19;30(2):379-94
- The German Collaborative Research Center 415 "specificity and pathophysiology of signal transduction pathways". Kabelitz D. Eur J Cell Biol. 2011 Jun-Jul;90(6-7):449.
- High expression of the immature laminin receptor protein correlates with mutated IGVH status and predicts a favorable prognosis in chronic lymphocytic leukemia. Friedrichs B, Siegel S, Reimer R, Barsoum A, Coggin J Jr, Kabelitz D, Heidorn K, Schulte C, Schmitz N, Zeis M. Leuk Res. 2011 Jun;35(6):721-9.
- Modulation of CD4+ T-cell activation by CD95 co-stimulation. Paulsen M, Valentin S, Mathew B, Adam-Klages S, Bertsch U, Lavrik I, Krammer PH, Kabelitz D, Janssen O. Cell Death Differ. 2011 Apr;18(4):619-31.
- Human NK cells require caspases for activation-induced proliferation and cytokine release but not for cytotoxicity. Ussat S, Scherer G, Fazio J, Beetz S, Kabelitz D, Adam-Klages S. Scand J Immunol. 2010 Nov;72(5):388-95
- Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2. Ellinghaus E, Ellinghaus D, Stuart PE, Nair RP, Debrus S, Raelson JV, Belouchi M, Fournier H, Reinhard C, Ding J, Li Y, Tejasvi T, Gudjonsson J, Stoll SW, Voorhees JJ, Lambert S, Weidinger S, Eberlein B, Kunz M, Rahman P, Gladman DD, Gieger C, Wichmann HE, Karlsen TH, Mayr G, Albrecht M, Kabelitz D, Mrowietz U, Abecasis GR, Elder JT, Schreiber S, Weichenthal M, Franke A. Nat Genet. 2010 Nov;42(11):991-5.
- Human γδ T lymphocytes for immunotherapeutic strategies against cancer. Kabelitz D. F1000 Med Rep. 2010 Jun 23;2.
